Cargando…
Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring
BACKGROUND AND AIMS: The feature of blood glucose dynamics in patients with chronic liver disease (CLD) is marked blood glucose fluctuations. However, the detail of blood glucose dynamics is not well known. The aim of the present study was to evaluate glycemic fluctuations by continuous glucose moni...
Autores principales: | Honda, Fumi, Hiramatsu, Akira, Hyogo, Hideyuki, Aikata, Hiroshi, Daijo, Kana, Teraoka, Yuji, Inagaki, Yuki, Morio, Kei, Kobayashi, Tomoki, Nakahara, Takashi, Nagaoki, Yuko, Kawaoka, Tomokazu, Yoneda, Masayasu, Tsuge, Masataka, Imamura, Michio, Kawakami, Yoshiiku, Ochi, Hidenori, Chayama, Kazuaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882130/ https://www.ncbi.nlm.nih.gov/pubmed/29614124 http://dx.doi.org/10.1371/journal.pone.0195028 |
Ejemplares similares
-
The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy
por: Nagaoki, Yuko, et al.
Publicado: (2017) -
Early experience of seven hepatocellular carcinoma cases treated with regorafenib
por: Uchikawa, Shinsuke, et al.
Publicado: (2018) -
Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis
por: Hiramatsu, Akira, et al.
Publicado: (2019) -
Three Children Treated with Direct-acting Antivirals for Chronic Hepatitis C Virus Genotype 1b Infection
por: Ohya, Kazuki, et al.
Publicado: (2019) -
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial
por: Hatooka, Masahiro, et al.
Publicado: (2018)